Webinar - Hot Topics In Genetic Testing and Surveillance For Children with Cancer Predisposition

Live Webinar

Monday, December 16, 2024

3:00-4:00pm CT

Description: 

Increased incorporation of germline genetic testing in pediatric oncology is uncovering cancer predispositions in more and more children. It is thus imperative that pediatric hematology oncology providers know which children warrant testing and what to do with the resulting information. Towards this end, it is debated whether children should be tested for germline variants in adult onset cancer predisposition genes. And for those who do test positive, does the information gained provide insights into tumor formation and/or provide new strategies for therapeutic intervention? As relates to cancer surveillance, it is often challenging to know when and how to monitor children with underlying predispositions and whether such monitoring is truly effective.

Further, are there more sensitive and accurate ways to screen for cancers in individuals at risk? In light of the increased availability and use of germline genetic testing, it is pediatric hematology oncology providers must know when and how to appropriately counsel, test and manage patients with underlying predispositions. This webinar will discuss new advances in the field to update current knowledge and spur conversations about these exciting topics.

Learning Objectives:

1.     Understand when and if testing for germline mutations in adult-onset cancer predisposition genes should be offered to children

2.     Recognize the benefits and challenges of surveillance across the full spectrum of cancer predisposition syndromes

3.     Know how testing for cell-free DNA can enhance cancer detection in individuals with Li Fraumeni syndrome

Speakers

• Kim Nichols, MD (moderator)
• Christian Kratz, MD
• Melissa Perrino, MD
• David Malkin, MD

To access the webinar on-demand, once registered, log into your ASPHO My Library account with your ASPHO username and password, and click on the video icon: - "Access the Webinar".